Latest PLoS ONE Stories
Pretreating the site of intradermal vaccination – vaccine delivered into the skin rather than to muscles beneath the skin – with a particular wavelength of laser light may substantially improve vaccine effectiveness without the adverse effects of chemical additives currently used to boost vaccine efficacy.
Poverty may have direct implications for important, early steps in the development of the brain, saddling children of low-income families with slower rates of growth in two key brain structures.
A new test has the potential to help physicians identify patients with the most lethal forms of triple-negative breast cancer, a disease which requires aggressive and innovative treatment.
The degree to which students' exam scores differ owes more to their genes than to their teachers, schools or family environments.
Blood clots play an unexpected role in protecting the body from the deadly effects of bacteria by absorbing bacterial toxins.
Investigators at the Institute for Genome Sciences at the University of Maryland School of Medicine have developed a new technique that can track the activity of a disease-causing microbe and the host cell response to that pathogen simultaneously.
The retinoblastoma (Rb) protein plays a critical role in suppressing the multi-step process of cell migration through the bloodstream, lymphovascular invasion and the metastasis of an aggressive type of breast cancer to the lung.
PLOS ONE publishes "Assessing Dangerous Climate Change: Required Reductions of Carbon Emissions to Protect Young People, Future Generations and Nature" from James Hansen and colleagues, and announces call for papers on responses to climate change.
Human papillomavirus, or HPV, which can cause cervical cancer in women, is also known to cause anal cancer in both women and men.
Physicians have long been taught that a physical examination is not complete without an assessment of whether a patient appears to be acutely or chronically ill.
PLoS Medicine is a peer-reviewed medical journal established in October 2004. It is the second journal of the Public Library of Sciences, which publishes open-access material. All material in PLoS Medicine is published under the Creative Commons license. To fund the journal, the publication’s business model requires that authors pay publication costs. PLoS Medicine provides an innovative and influential venue for research and comment on the major challenges to human health worldwide. It...
PLoS Biology is a peer-reviewed scientific journal covering all aspects of biology. It was established in 2003, with the first issue published in October of that year. It was the first journal of the Public Library of Science. As of May 2012, the current editor-in-chief is Jonathan Eisen (University of California, Davis). All content in PLoS Biology is published under the Creative Commons “by-attribution” license. The journal is funded by authors who are charged set fees to publish...
PLoS ONE is an open-access peer-reviewed scientific journal published by the Public Library of Science (PLoS). It was established in 2006 as a beta version. In August 2008 it moved from a weekly publication schedule to a daily one, publishing articles as soon as they became ready. In October 2008, it came out of “beta.” In September 2009, PLoS ONE made full online usage of every published article publicly available. The founding managing editor was Chris Surridge. He was succeeded by...
- A gift; a largess; a gratuity; a present; a dole.